Cancer cells killed in mice using copper-based nanomaterials
Copper oxide nanoparticles have successfully killed tumour cells in mice and when combined with immunotherapy, could work as a vaccine for cancer.
List view / Grid view
Copper oxide nanoparticles have successfully killed tumour cells in mice and when combined with immunotherapy, could work as a vaccine for cancer.
Researchers have mapped a previously uncharted region of the human genome which could lead to tests for certain conditions in the future.
A research team have used genome editing to correct two of the mutations that cause cystic fibrosis.
A collaboration between Prof Lucía Chávez-Gutiérrez and Prof Bart De Strooper of VIB-KU Leuven has revealed the molecular basis of the hereditary form of Alzheimer’s disease that strikes early in life.
The successful combination of two therapies results in the growth of specialised vessels that deliver cancer-fighting immune cells to a tumour, potentially leading to more effective treatments and longer survival periods.
Cells behave differently when removed from their environments, just as cells that develop in cultures do not behave like cells in living creatures.
4 July 2016 | By Victoria White, Digital Content Producer
Scientists have shown that NEAT1, a non-coding RNA, plays an important role in the survival of highly dividing cells - and in particular of cancer cells...
17 May 2016 | By Katie Sadler
Virologists have discovered that an antiviral drug against hepatitis C has helped slow down the development of Zika virus in Mice.
7 March 2016 | By Victoria White
A team, led by Professor Elena Levtchenko from KU Leuven, discovered that kidney stem cells are abundant in the urine of premature babies...
3 March 2016 | By Victoria White
Combined with chemotherapy, a novel cell-based immunotherapy drastically increased the survival rates of mice afflicted with brain tumours. Almost 50% of the mice were completely cured...